Trop-2 Archives - BJBMS Viewpoints

September 28, 2022

Latest posts

[ September 26, 2022 ] CAV1 is a potential marker for distinguishing benign prostatic hyperplasia and prostate cancer patients Author Summary
[ September 19, 2022 ] Fusion genes can improve outcomes in B-cell precursor acute lymphoblastic leukemia patients Author Summary
[ September 13, 2022 ] The circulating isoform of the urokinase plasminogen activator receptor may aid in predicting prognosis for cancer patients Author Summary
[ September 5, 2022 ] Should older esophageal cancer patients get a different course of treatment? Author Summary
[ September 2, 2022 ] The Reviewer of the Month for September 2022: Dr Aly El-Makhzangy Reviewer of the month

New therapeutic option for the patients with metastatic triple-negative breast cancer: Sacituzumab govitecan-hziy

April 28, 2020 0

By Semir Vranic, MD, PhD Bosnian Journal of Basic Medical Sciences Editor in Chief Food and Drug Administration (FDA) has just granted accelerated approval to sacituzumab govitecan-hziy (TRODELVY, Immunomedics, Inc.) for the patients with metastatic […]

BJBMS Viewpoints

Science in plain words

Trop-2

New therapeutic option for the patients with metastatic triple-negative breast cancer: Sacituzumab govitecan-hziy

What matters the most when choosing the journal to submit your article?